We are live on ! Find out more
COLL icon

Collegium Pharmaceutical

159 hedge funds and large institutions have $603M invested in Collegium Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 48 increasing their positions, 50 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 21

24% more call options, than puts

Call options by funds: $1.47M | Put options by funds: $1.19M

15% more funds holding

Funds holding: 138159 (+21)

13.88% more ownership

Funds ownership: 93.98%107.86% (+14%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 50

7% less capital invested

Capital invested by funds: $649M → $603M (-$45.2M)

Holders
159
Holders Change
+21
Holders Change %
+15.22%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
44
Increased
48
Reduced
50
Closed
21
Calls
$1.47M
Puts
$1.19M
Net Calls
+$282K
Net Calls Change
-$744K
Name Holding Trade Value Shares
Change
Change in
Stake
HW
101
Hancock Whitney
Mississippi
$356K +$105K +5,102 +31%
Prudential Financial
102
Prudential Financial
New Jersey
$356K +$451K +21,828 New
Manulife (Manufacturers Life Insurance)
103
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$336K +$18.6K +901 +5%
JP Morgan Chase
104
JP Morgan Chase
New York
$316K +$183K +8,843 +84%
AIG
105
American International Group
New York
$311K -$22.7K -1,099 -5%
SFM
106
Systematic Financial Management
New Jersey
$309K +$390K +18,915 New
DCM
107
Dupont Capital Management
Delaware
$308K +$389K +18,835 New
Voloridge Investment Management
108
Voloridge Investment Management
Florida
$307K +$94.9K +4,597 +32%
SAM
109
Sawgrass Asset Management
Florida
$296K +$374K +18,100 New
APM
110
Avidity Partners Management
Texas
$278K -$3.36M -163,000 -91%
VOYA Investment Management
111
VOYA Investment Management
Georgia
$268K +$15.1K +730 +5%
FQ
112
First Quadrant
California
$266K -$211K -10,220 -39%
JMPWA
113
JP Morgan Private Wealth Advisors
California
$250K +$33.1K +1,606 +12%
State Board of Administration of Florida Retirement System
114
State Board of Administration of Florida Retirement System
Florida
$247K
BCM
115
Bayesian Capital Management
New York
$234K +$295K +14,300 New
MIM
116
MetLife Investment Management
New Jersey
$229K
Bank of America
117
Bank of America
North Carolina
$226K -$12.3K -597 -4%
T. Rowe Price Associates
118
T. Rowe Price Associates
Maryland
$222K -$1.7M -82,560 -86%
Royal Bank of Canada
119
Royal Bank of Canada
Ontario, Canada
$213K -$194K -9,397 -42%
Citigroup
120
Citigroup
New York
$203K -$150K -7,255 -37%
Bessemer Group
121
Bessemer Group
New Jersey
$199K +$252K +12,200 New
SG Americas Securities
122
SG Americas Securities
New York
$197K +$124K +5,990 +99%
SRAM
123
Stone Ridge Asset Management
New York
$193K -$237K -11,500 -49%
IWM
124
IHT Wealth Management
Illinois
$187K +$2.31K +112 +1%
OSAM
125
O'Shaughnessy Asset Management
Connecticut
$186K +$235K +11,365 New

COLL Hedge Fund Activity: Q1 2020 in Review

159 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2020, worth a combined $603M — down 7% from $649M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new COLL positions and 21 closed out — a net gain of 23 holders — while 48 added to existing stakes and 50 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $41.3M. The largest seller was Frazier Management, cutting an estimated $19.5M.

  • 159 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2020, up from 138 in Q4 2019.
  • Funds reported $603M of Collegium Pharmaceutical stock for Q1 2020, down 7% quarter-over-quarter.
  • 44 funds opened new Collegium Pharmaceutical positions in Q1 2020 and 21 closed out, a net change of +23 holders.
  • The largest Collegium Pharmaceutical buyer in Q1 2020 was Camber Capital Management, an estimated $41.3M added.
  • The largest Collegium Pharmaceutical seller in Q1 2020 was Frazier Management, an estimated $19.5M sold.

Based on aggregated 13F filings for Q1 2020.